Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Equity

v3.25.0.1
Consolidated Statements of Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings/(Accumulated Deficit)
Accumulated Other Comprehensive Income/(Loss)
Treasury Stock, Common
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares, Outstanding   92.0        
Balance as of beginning of period, value at Dec. 31, 2021 $ 1,089 $ 1 $ 1,543 $ 79 $ (15) $ (519)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 355     355    
Other comprehensive income (loss) 53       53  
Dividends 116     116    
Stock Repurchased During Period, Shares   (6.0)        
Repurchase of common stock (445)         (445)
Net Share Settlement of Incentive Equity Awards (11)   (11)      
Net income 33   33      
Stock Issued During Period, Value, Stock Options Exercised 4   4      
Balance as of end of period, value at Dec. 31, 2022 962 $ 1 1,569 318 38 (964)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares, Outstanding   86.0        
Net income 289     289    
Other comprehensive income (loss) (19)       (19)  
Dividends 119     119    
Stock Repurchased During Period, Shares   (5.0)        
Repurchase of common stock (397)         (397)
Net Share Settlement of Incentive Equity Awards (9)   (9)      
Net income 38   38      
Stock Issued During Period, Value, Stock Options Exercised     1      
Stockholders' Equity, Other 1          
Balance as of end of period, value at Dec. 31, 2023 746 $ 1 1,599 488 19 (1,361)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares, Outstanding   81.0        
Net income 289          
Other comprehensive income (loss) (2)       (2)  
Dividends 123     123    
Stock Repurchased During Period, Shares   (4.0)        
Repurchase of common stock (308)         (308)
Net Share Settlement of Incentive Equity Awards (20)   (20)      
Net income $ 45   45      
Exercised (in shares) 0.4 1.0        
Stock Issued During Period, Value, Stock Options Exercised $ 22   22      
Stockholders' Equity, Other 1   1      
Balance as of end of period, value at Dec. 31, 2024 $ 650 $ 1 $ 1,647 $ 654 $ 17 $ (1,669)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares, Outstanding   78.0